Armata Pharmaceuticals, Inc. (ARMP) Net income 2016–2025
Armata Pharmaceuticals, Inc. (ARMP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$173.8MFY2025 · since FY2016: -$18.8M → -$173.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$173.8M | -818.8% |
| FY2024 | -$18.9M | +72.6% |
| FY2023 | -$69.0M | -87.0% |
| FY2022 | -$36.9M | -59.4% |
| FY2021 | -$23.2M | -4.4% |
| FY2020 | -$22.2M | -13.9% |
| FY2019 | -$19.5M | -16.6% |
| FY2018 | -$16.7M | -30.1% |
| FY2017 | -$12.8M | +31.9% |
| FY2016 | -$18.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice